BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 33485650)

  • 1. mRNA COVID-19 vaccine is well tolerated in patients with cutaneous and systemic mastocytosis with mast cell activation symptoms and anaphylaxis.
    Rama TA; Moreira A; Castells M
    J Allergy Clin Immunol; 2021 Mar; 147(3):877-878. PubMed ID: 33485650
    [No Abstract]   [Full Text] [Related]  

  • 2. Delving Into COVID-19 Vaccination-Induced Anaphylaxis: Are mRNA Vaccines Safe in Mast Cell Disorders?
    Azenha Rama T; Álvarez-Twose I
    J Investig Allergol Clin Immunol; 2021 Apr; 31(2):193-195. PubMed ID: 33574015
    [No Abstract]   [Full Text] [Related]  

  • 3. Potential mechanisms of anaphylaxis to COVID-19 mRNA vaccines.
    Risma KA; Edwards KM; Hummell DS; Little FF; Norton AE; Stallings A; Wood RA; Milner JD
    J Allergy Clin Immunol; 2021 Jun; 147(6):2075-2082.e2. PubMed ID: 33857566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutralizing SARS-CoV-2.
    Poeschla E
    Elife; 2020 Dec; 9():. PubMed ID: 33320086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Not Available].
    Meylan P
    Rev Med Suisse; 2020 Oct; 16(709):1895. PubMed ID: 33026736
    [No Abstract]   [Full Text] [Related]  

  • 6. Vaccine-induced protection in aging adults and pandemic response.
    Schenkelberg T
    Biochem Biophys Res Commun; 2021 Jan; 538():218-220. PubMed ID: 33213845
    [No Abstract]   [Full Text] [Related]  

  • 7. Could mixing COVID vaccines boost immune response?
    Ledford H
    Nature; 2021 Feb; 590(7846):375-376. PubMed ID: 33547431
    [No Abstract]   [Full Text] [Related]  

  • 8. Antibody Titers Before and After a Third Dose of the SARS-CoV-2 BNT162b2 Vaccine in Adults Aged ≥60 Years.
    Eliakim-Raz N; Leibovici-Weisman Y; Stemmer A; Ness A; Awwad M; Ghantous N; Stemmer SM
    JAMA; 2021 Dec; 326(21):2203-2204. PubMed ID: 34739043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insights from American College of Allergy, Asthma, and Immunology COVID-19 Vaccine Task Force: Allergic Reactions to mRNA SARS-CoV-2 Vaccines.
    Murphy KR; Patel NC; Ein D; Hudelson M; Kodoth S; Marshall GD; Parikh P; Blaiss MS
    Ann Allergy Asthma Immunol; 2021 Apr; 126(4):319-320. PubMed ID: 33493641
    [No Abstract]   [Full Text] [Related]  

  • 10. Why Oxford's positive COVID vaccine results are puzzling scientists.
    Callaway E
    Nature; 2020 Dec; 588(7836):16-18. PubMed ID: 33230278
    [No Abstract]   [Full Text] [Related]  

  • 11. Lessons From Bacille Calmette-Guérin for SARS-CoV-2 Vaccine Candidates.
    Behr MA; Divangahi M; Schurr E
    J Infect Dis; 2021 Feb; 223(2):189-191. PubMed ID: 33535239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How COVID unlocked the power of RNA vaccines.
    Dolgin E
    Nature; 2021 Jan; 589(7841):189-191. PubMed ID: 33437061
    [No Abstract]   [Full Text] [Related]  

  • 13. UK science advisers: publish evidence behind COVID vaccine changes.
    Nature; 2021 Jan; 589(7841):169-170. PubMed ID: 33437064
    [No Abstract]   [Full Text] [Related]  

  • 14. Risk of allergic reaction in patients with atopic disease and recent coronavirus disease 2019 vaccination.
    Dages KN; Pitlick MM; Joshi AY; Park MA
    Ann Allergy Asthma Immunol; 2021 Aug; 127(2):257-258. PubMed ID: 33962029
    [No Abstract]   [Full Text] [Related]  

  • 15. Necessity of 2 Doses of the Pfizer and Moderna COVID-19 Vaccines.
    Livingston EH
    JAMA; 2021 Mar; 325(9):898. PubMed ID: 33533893
    [No Abstract]   [Full Text] [Related]  

  • 16. Allergic Reactions and Anaphylaxis to LNP-Based COVID-19 Vaccines.
    Moghimi SM
    Mol Ther; 2021 Mar; 29(3):898-900. PubMed ID: 33571463
    [No Abstract]   [Full Text] [Related]  

  • 17. Messengers of hope.
    Nat Biotechnol; 2021 Jan; 39(1):1. PubMed ID: 33376248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 vaccine race: watch your step for cancer patients.
    Fanciullino R; Ciccolini J; Milano G
    Br J Cancer; 2021 Mar; 124(5):860-861. PubMed ID: 33288844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A promising inactivated whole-virion SARS-CoV-2 vaccine.
    Isakova-Sivak I; Rudenko L
    Lancet Infect Dis; 2021 Jan; 21(1):2-3. PubMed ID: 33069282
    [No Abstract]   [Full Text] [Related]  

  • 20. How can countries stretch COVID vaccine supplies? Scientists are divided over dosing strategies.
    Ledford H
    Nature; 2021 Jan; 589(7841):182. PubMed ID: 33437062
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 24.